This work aims at identifying an effective protocol to raise anti-Leishmania chagasi amastigote antibodies in different animal species. Protocols of immunization by subcutaneous injections of L. chagasi promastigote and amastigote lysates or by either intravenous or subcutaneous inoculation of live metacyclic promastigotes were assessed in mice, rabbits, and dogs. The immunization with live promastigotes produced a strong humoral immune response against L. chagasi amastigotes in all three animal species. The sera from animals immunized with the promastigote lysate did not react with amastigotes and, conversely, the sera from mice immunized with the amastigote lysate did not react with promastigotes. Taken all data together, the immunization through infection with metacyclic promastigotes was considered the most satisfactory way to immunize animals for obtaining anti-amastigote and anti-promastigote antibodies, since it did not only allowed the obtention of antibody against the two forms of the parasite, but it is also cheap, less laborious than carrying out the purification of amastigotes from infected tissues and avoid the use of a large number of hamsters for obtention the amastigotes, necessary to produce the immunogenic lysates. Furthermore, this immunization protocol was comparable to the amastigote lysate immunization protocol for the obtaining of mouse monoclonal antibodies (mAbs). #
Introduction
American visceral leishmaniasis (AVL), a chronic parasitic disease caused by Leishmania chagasi in the Veterinary Immunology and Immunopathology 99 (2004) [135] [136] [137] [138] [139] [140] [141] Abbreviations: AVL, American visceral leishmaniasis; IFA, incomplete Freund's adjuvant; mAbs, monoclonal antibodiesNew World, constitutes a serious public health problem in Brazil. It is characterized by intense macrophage parasitism by the Leishmania amastigote form, which is responsible for the pathogenesis of the disease (Chakrabarty et al., 1996; Lucena et al., 1996; Alexander et al., 1999) . Many immunoparasitological studies on this disease require anti-Leishmania antibodies, which are generally produced through the immunization of animals with promastigote lysates. The promastigote, which is the vector stage of the parasite, is easily obtained from liquid cultures (Hendricks et al., 1978; Jaffe et al., 1984a, b) . However, it differs antigenically from the amastigote (Sadick and Raff, 1985; Brandonisio et al., 2000; Teixeira et al., 2002) , the stage that is present in the mammal host from a few hours after the beginning till the end of the infection.
Animal immunization protocols leading to the production of high levels of polyclonal anti-amastigote antibodies or to activated Leishmania-specific B cells for hybridoma and monoclonal antibody production are highly desirable. These antibodies can be of use for parasite detection in clinical specimens, for antigen purification procedures by immunoprecipitation or immunochromatography and for the development of more specific and non-invasive immunodiagnostic techniques such as detection of parasite antigens in patient's sera (Ismail et al., 1997; Hassan et al., 1998; Mansour et al., 1998; Garcia et al., 2002) . Several protocols for the immunization of mice with different types of antigens have been described, aiming at obtaining anti-Leishmania monoclonal antibodies (mAbs) (Jaffe et al., 1984a, b; Anthony et al., 1985; Magill et al., 1993; Dabés Guimarães et al., 1996; Afrin and Ali, 1998) . However, no comparison among these different protocols is available.
In this work, protocols for the immunization of mice, rabbits, and dogs were tested for their possible elicitation of a strong humoral response against L. chagasi amastigotes. Differences in the intensities of antibody production against promastigote or amastigote forms of L. chagasi, following either immunization with killed parasites or the infection of animals were found. Spleen cells from the immunized mice could be used for the production of hybridomas secreting anti-amastigote monoclonal antibodies.
Materials and methods

Parasites and parasite lysates
L. chagasi (MHOM/BR2000/Merivaldo2 strain) metacyclic promastigotes were obtained by cultivation of promastigotes in Schneider's medium (Schneider's insect medium, Sigma Chemical Co., St. Louis, Missouri, USA) until the stationary phase, at 23 8C. L. chagasi amastigotes were obtained from the spleens of hamsters infected with 1 Â 10 8 L. chagasi metacyclic promastigotes and purified by centrifugation on a Percoll solution gradient (Chang, 1980; Taylor and Williams, 1992) . Leishmania amazonensis and Leishmania braziliensis amastigotes were obtained by in vitro axenization of promatigotes (Teixeira et al., 2002) . Lysates of both promastigote and amastigote forms were obtained by sonication (five cycles of 30 s with intermediate cooling cycles of 1 min at 80% output; Branson sonifier 450 W, Branson Instruments, Danbury, CT). The lysates were assayed for protein contents by means of a reaction with fluorescamine and kept cryopreserved at À70 8C till use. The promastigotes derived from amastigotes obtained from hamster spleens cultures were not subjected to more than 10 in vitro culture passages.
Immunizations
Groups of 4 to 10 BALB/c mice were immunized by means of the following protocols: (a) three biweekly subcutaneous injections of amastigote lysates containing 200 mg of protein emulsified in incomplete Freud's adjuvant (IFA); (b) three biweekly subcutaneous inoculations of metacyclic promastigote lysates containing 200 mg of protein emulsified in IFA; (c) infection by weekly intravenous injection with 5 Â 10 7 live L. chagasi metacyclic promastigotes, for seven consecutive weeks.
A group of four rabbits was immunized by means of the following protocol: (a) four biweekly injections by the subcutaneous route of 1 Â 10 8 amastigote lysate emulsified in IFA or (b) five biweekly intravenous injections of 1 Â 10 8 live L. chagasi metacyclic promastigotes.
Four dogs were initially immunized with two biweekly injections by the subcutaneous route, of promastigote lysate (1 Â 10 8 parasites/animal) emulsified in IFA. Four weeks later, the same animals were infected by one subcutaneous injection of 1 Â 10 8 live L. chagasi metacyclic promastigotes. Control groups of three dogs, three rabits and five mice were injected only with saline at the same intervals.
The effectiveness of the immunization was tested by indirect ELISA as described below. Mice sera were tested, at the 8 day after the last booster and the best responders were selected for spleen cell-myeloma cell fusion. Rabbit sera were tested 14 days after last booster. The effectiveness of dog immunization with promastigote lysate was measured 14 days after the antigen booster and at 11 months after the inoculation of live promastigotes.
Clinical follow up of infected animals
After immunization with live metacyclic promastigote mice remained with sub-clinical infection for at least 2 months when the last cell fusion was carried out. No clinical signs of visceral leishmaniasis, such as loss of weight, cachexia, alopecia, onycogryphosis or any other disease signs were observed during the experiment period in mice, rabbits or dogs.
Indirect ELISA
Sera of all groups of animals were assayed by indirect ELISA, for the presence of antibodies against L. chagasi amastigotes and promastigotes, as previouly described (Paranhos-Silva et al., 1998) . Briefly, microtiter plates wells (Corning Laboratory Science Co., NY, USA) were coated by incubation with 2 mg of L. chagasi amastigote or promastigote lysates in 100 ml of 0.1 M carbonate buffer, pH 9.6, followed by successive incubations with: (a) blocking solution consisting of 10% skimmed milk; (b) four dilutions of each test sera in phosphate buffered saline, pH 7.4 (PBS) containing 5% skimmed milk (W:V); (c) peroxidase-conjugated (Sigma Chemicals, St. Louis, USA) antibodies against mouse, rabbit or dog IgG and (d) the chromogenic substance O-phenylenediamine (Sigma Chemical Co., St. Louis, Missouri, USA) and the substrate hydrogen peroxide. The reaction was read using a micro titer reader at 450 nm filter (Dynatech Laboratories, Alexandria, VA, USA). Positive and negative controls included in the plates were respectively, sera from L. chagasi experimentally infected or non-infected mice, rabbits, and dogs.
Hybridoma production and characterization of monoclonal antibodies
The best responders mice of groups immunized with amastigote lysate and infected with alive promastigotes were selected for cellular fusion. Three days after an intravenous booster with 200 mg of amastigote lysate, the animals were sacrificed and their spleen cells submitted to fusion with SP2-0 mieloma cells, according to Jaffe et al. (1984a, b) . The hybridomas obtained were screened for the production of anti-Leishmania antibodies, by testing the supernatants reactivity against L. chagasi amastigote antigens by ELISA. Their immmunogobulin sub-classes were determined by a capture ELISA using a commercially available kit (Pharmingen, Los Angeles, CA, USA), and their reactivities to Leishmania species and stages were determined by indirect ELISA as stated above, and by Western-blot, using as antigens amastigote and promastigote lysates of L. chagasi, L. amazonensis, and L. braziliensis and promastigote lysate of Leishmania major. For the Western blots, 10 8 promastigote and 7 Â 10 8 amastigote forms were resuspended in 100 ml of SDS-sample buffer and boiled for 3 min (denatured) or not boiled (non-denatured). After microcentrifugation, the supernatants were loaded to 10% SDS-PAGE gels and subjected to Western-blot using the same reagents used for the indirect ELISA detailed above.
The capacity of the mAbs to recognize L. chagasi amastigotes in paraffin-embedded tissue was investigated by testing undiluted supernatants on L. chagasiinfected hamster liver sections, previously fixed with formaldehyde, embedded with paraffin, deparaffinazed, and developed with the use of an anti-mouse immunoglobulin-peroxidase conjugate (Dako, Carpinteria, CA, USA), and a precipitating chromogenic substrate solution containing 3,3 0 -diamino benzidine (Sigma Chemical Co., St. Louis, USA) and hydrogen peroxide (Sigma Chemical Co., St. Louis, USA), according to Livni et al. (1983) . Sections incubated with normal mouse serum diluted 1:200 in saline were used as negative controls.
Results
Sera from mice immunized with promastigote lysate reacted only with promastigote antigens, and sera from mice immunized with amastigote lysate reacted only with amastigote antigens in an ELISA. On the other hand, the sera of animals infected with live metacyclic promastigotes reacted with both parasite stages (Fig. 1) . Similar results were obtained with the rabbit (Fig. 2 ) and dog immunizations (Fig. 3) . Sera from the negative control animals reacted only at back-ground levels (OD less than 0.1) with the tested Leishmania antigens (not shown).
The fusion of splenocytes from mice immunized with the amastigote lysate with mieloma cells generated three hybrid clones producing anti-L. chagasi amastigote IgG1 antibodies; the fusion carried out with splenocytes from mice infected with live metacyclic promastigotes generated seven clones, six producing IgG2a, and one IgM mAbs (data not shown).
Four of those mAbs were tested by ELISA against four Leishmania species. The IgG2a mAbs reacted only with L. chagasi amastigotes, while the IgM mAb reacted with L. chagasi, L. braziliensis, and L. amazonensis amastigotes and promastigotes with L. major promastigotes (Fig. 4A1 and A2) .
The seven mAbs oobtained from mice infected with live metacyclic promastigotes, were used in a Western-blot for determination of the apparent molecular weights of the recognized L. chagasi amastigote antigens. The six IgG2a mAbs recognized two non-denatured L. chagasi amastigote proteins, with 35 and 68 kDa. The IgM mAb reacted with a denatured and non-denatured 60 kDa protein (Fig. 4B1 and B2) .
One of the IgG2A mAbs successfully stainned L. chagasi amastigotes in paraffin-embedded L. chagasiinfected hamster liver sections fixed with formaldehyde (Fig. 4C) .
Discussion
The immunization of mice with Leishmania lysates elicited the production of stage-specific antibodies, i.e., sera from mice immunized with promastigote lysate did not react with amastigote antigens, and sera from mice immunized with amastigote lysate did not react with promastigote antigens, putting in evidence the antigenic differences between the two leishmanial forms. On the other hand, the sera of animals immunized with live metacyclic promastigotes reacted with both parasite stages.
The protocols of mouse immunization with amastigote lysate and of mouse infection with live metacyclic promastigotes were effective in terms of allowing the production of anti-amastigote antibody-secreting mouse hybridomas.
From the three immunization protocols tested in this work, two, the immunization with amastigote lysate and the infection with live promastigotes were indeed capable of evoking a strong response against L. chagasi. The infection with live metacyclic promastigotes, is of easy execution, since it just requests the cultivation of promastigote forms of the parasite, which is readily performed and reproducible, while the immunization protocol using amastigote antigens demands the infection and culling of several infected hamsters for obtaining the parasite, procedures that are not ethically justifiable if they can be avoided. In addition, the techniques for obtaining purified amastigotes from infected animal tissues are highly laborious, time consuming, dependent on technical skill and subjected to variations in terms of degree of contamination by the host tissue debris.
A disadvantage, in terms of ethical considerations, of infecting mice, dogs or rabbits with L. chagasi promastigotes for immunization purpose, could be considered. However, mice and dogs are relatively resistant to experimental L. chagasi infection, despite the detection of amastigotes in their internal organs (Oliveira et al., 1993; Streit et al., 2001 ) and rabbits seem to be completely refractory to the infection (Rassam et al., 1984) . In fact, all infected animals in the experiment described herein had no clinical signs of the disease throughout the experimental period.
In view of the several advantages stated above, the animal immunizations with live metacyclic promastigotes of L. chagasi presented in this work was considered the most practical way for obtaining a strong humoral answer against amastigotes forms of this parasite, with high sera levels of anti-amastigote antibodies in the three tested animal species. The immunization with live promastigote and amastigote lysates were comparable in terms of allowing the obtaining of anti-amastigote mAb-producing hybridoma. Furthermore, both immunization generated antibody useful for immunohistochemical assays. Although not shown in this paper, the immunization with live promastigote induced a positive in vitro lymphoproliferative response to L. chagasi, which could be used as a positive control response on phase I vaccine efficiency studies (Teixeira et al., unpublished data) .
Conclusion
Taken all data together, the immunization with live metacyclic promastigotes was considered the most satisfactory way to immunize animals for obtaining anti-amastigote antibodies. This immunization protocol was also comparable to the amastigote lysate immunization protocol for the obtaining of mouse monoclonal antibodies. Amastigotes were detected in a L. chagasi infected-hamster liver section by immunohistochemistry using an IgG2a mAb as the first antibody, as detailed in Section 2 (E). Note the absence of stained structures in a section incubated with a normal mouse serum dilution instead of the mAb (F).
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